The University of Chicago Header Logo

Connection

Helen S. Te to Middle Aged

Back to Details
This is a "connection" page, showing publications Helen S. Te has written about Middle Aged.
Helen S. Te
Connection Strength
0.549
Middle Aged
  1. Hepatitis B transmission/reactivation associated with Hepatitis B core antibody and Hepatitis C nucleic acid testing positive organs: A report from the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee. Transpl Infect Dis. 2024 Nov; 26 Suppl 1:e14305.
    View in: PubMed
    Score: 0.061
  2. Involution of Portal Hypertensive Gastric and Duodenal Polyps Following Liver Transplantation. Clin Gastroenterol Hepatol. 2019 06; 17(7):e77-e78.
    View in: PubMed
    Score: 0.041
  3. Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis. Dig Dis Sci. 2016 12; 61(12):3621-3626.
    View in: PubMed
    Score: 0.036
  4. Refractory Autoimmune Hepatitis: Beyond Standard Therapy. Dig Dis Sci. 2016 06; 61(6):1757-62.
    View in: PubMed
    Score: 0.034
  5. Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start? Dig Dis Sci. 2015 Oct; 60(10):3130-5.
    View in: PubMed
    Score: 0.032
  6. Hepatitis E virus infection in a liver transplant recipient in the United States: a case report. Transplant Proc. 2013 Mar; 45(2):810-3.
    View in: PubMed
    Score: 0.028
  7. Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clin Transplant. 2012 Nov-Dec; 26(6):826-32.
    View in: PubMed
    Score: 0.026
  8. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant. 2008 Jul; 27(7):753-9.
    View in: PubMed
    Score: 0.020
  9. Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety. Dig Dis Sci. 2005 Apr; 50(4):719-26.
    View in: PubMed
    Score: 0.016
  10. Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause. 2004 Sep-Oct; 11(5):575-7.
    View in: PubMed
    Score: 0.016
  11. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Liver Transpl. 2003 Jul; 9(7):733-6.
    View in: PubMed
    Score: 0.014
  12. Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl. 2003 Mar; 9(3):248-53.
    View in: PubMed
    Score: 0.014
  13. Group G streptococcal bacteremia and de novo hepatocellular carcinoma after liver transplantation. Liver Transpl. 2002 Jun; 8(6):572.
    View in: PubMed
    Score: 0.013
  14. Long-term follow-up of liver transplant recipients undergoing cyclosporine withdrawal. Transplant Proc. 2001 Aug; 33(5):2874-7.
    View in: PubMed
    Score: 0.013
  15. Open cardiotomy for removal of migrating transjugular intrahepatic portosystemic shunt stent combined with liver transplantation. Transplantation. 2001 Apr 15; 71(7):1000-3.
    View in: PubMed
    Score: 0.012
  16. Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes. Hepatology. 2021 04; 73(4):1464-1477.
    View in: PubMed
    Score: 0.012
  17. Donor liver uridine diphosphate (UDP)-glucuronosyltransferase-1A1 deficiency causing Gilbert's syndrome in liver transplant recipients. Transplantation. 2000 May 15; 69(9):1882-6.
    View in: PubMed
    Score: 0.012
  18. Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. J Heart Lung Transplant. 2019 09; 38(9):997-999.
    View in: PubMed
    Score: 0.011
  19. Fulminant hepatic failure secondary to malignant melanoma: case report and review of the literature. Am J Gastroenterol. 1999 Jan; 94(1):262-6.
    View in: PubMed
    Score: 0.011
  20. A case of Q fever after liver transplantation. Transpl Infect Dis. 2017 Oct; 19(5).
    View in: PubMed
    Score: 0.009
  21. Accepting Hearts From Hepatitis C-Positive Donor: Can We Expand the Donor Pool? J Card Fail. 2017 Oct; 23(10):762-764.
    View in: PubMed
    Score: 0.009
  22. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLoS One. 2017; 12(3):e0173499.
    View in: PubMed
    Score: 0.009
  23. Sofosbuvir plus ledispasvir for recurrent hepatitis C in liver transplant recipients. Liver Transpl. 2016 11; 22(11):1536-1543.
    View in: PubMed
    Score: 0.009
  24. Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. Am J Gastroenterol. 2016 09; 111(9):1297-304.
    View in: PubMed
    Score: 0.009
  25. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016 May; 31(5):1025-30.
    View in: PubMed
    Score: 0.009
  26. Multiphase Multi-Detector Row Computed Tomography Imaging Characteristics of Large (>5 cm) Focal Hepatocellular Carcinoma. J Comput Assist Tomogr. 2016 May-Jun; 40(3):493-7.
    View in: PubMed
    Score: 0.009
  27. Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study. Aliment Pharmacol Ther. 2016 Jan; 43(1):134-44.
    View in: PubMed
    Score: 0.008
  28. An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med. 2014 Dec 18; 371(25):2375-82.
    View in: PubMed
    Score: 0.008
  29. Co-management between hospitalist and hepatologist improves the quality of care of inpatients with chronic liver disease. J Clin Gastroenterol. 2014 Apr; 48(4):e30-6.
    View in: PubMed
    Score: 0.008
  30. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology. 2012 Nov; 56(5):1741-50.
    View in: PubMed
    Score: 0.007
  31. Racial differences in fibrosis progression after HCV-related liver transplantation. Transplantation. 2012 Jul 27; 94(2):178-84.
    View in: PubMed
    Score: 0.007
  32. Evaluation of early null response to pegylated interferon and ribavirin as a predictor of therapeutic nonresponse in patients undergoing treatment for chronic hepatitis C. Am J Gastroenterol. 2011 Mar; 106(3):452-8.
    View in: PubMed
    Score: 0.006
  33. A case of adult hepatic toxocariasis. Nat Clin Pract Gastroenterol Hepatol. 2008 Jun; 5(6):344-8.
    View in: PubMed
    Score: 0.005
  34. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation. Transplant Proc. 2007 Dec; 39(10):3261-5.
    View in: PubMed
    Score: 0.005
  35. The safety and outcome of joint replacement surgery in liver transplant recipients. Liver Transpl. 2003 Apr; 9(4):373-6.
    View in: PubMed
    Score: 0.004
  36. Varicella infection following varicella vaccination in a liver transplant recipient. Am J Transplant. 2002 Oct; 2(9):880-2.
    View in: PubMed
    Score: 0.003
  37. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. Am J Gastroenterol. 2001 Oct; 96(10):2984-91.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.